NSTK · 01.2026Independent supplement reference
NutriStack
Edition 1.0Updated August 1, 2026

Supplement × Prescription·Evidence index

L-Arginine and Lisinopril: what the published research says

PubMed indexes 3 records that name L-Arginine and Lisinopril together, either in the title or in an interaction, co-administration, or pharmacokinetic context. Each one is listed below with its study design and, where the abstract states one, the authors’ own conclusion, quoted and linked. This page reports that literature. It does not tell you whether to combine them.

Read this first

An evidence index, not guidance.

Every statement below is attributed to a named, dated, linked source.

This page lists published research relevant to L-Arginine and Lisinopril. It deliberately does not state whether the combination is safe, whether it interacts, in which direction, at what dose, or how far apart to take them.

The research

3 studies naming L-Arginine and Lisinopril.

Strongest relevance first: papers naming both substances in the title, then human trials and systematic reviews.

L-arginine and lisinopril supplementation protects against sodium fluoride-induced nephrotoxicity and hypertension by suppressing mineralocorticoid receptor and angiotensin-converting enzyme 3 activity.

Environmental science and pollution research international · 2023 · PMID 36319925

Human subjects

“The results of this study suggest that L-arginine and lisinopril normalized blood pressure, reduced oxidative stress, and the expression of renal ACE and mineralocorticoid receptor, and improved nitric oxide production. Thus, L-arginine holds promise as a potential therapy against hypertension and renal damage.”

Ajibade et al. · From the abstract

Names both L-Arginine and Lisinopril in its title.

Combining lisinopril and l-arginine slows disease progression and reduces endothelin-1 in passive Heymann nephritis.

Kidney international · 2003 · PMID 12911535

Animal study

“Combining l-arginine with ACE inhibitors would represent a novel strategy for patients with severe nephropathy not completely responsive to ACE inhibition. Restoring the nitric oxide/ET-1 balance could be of benefit in halting renal disease progression.”

Zoja et al. · Authors' conclusion

Names both L-Arginine and Lisinopril in its title.

Effects of certain vasoactive agents on the long-term pattern of blood pressure, heart rate, and motor activity in cats.

American journal of veterinary research · 1997 · PMID 9185974

Clinical TrialControlled Clinical TrialAnimal study

“Although a diurnal pattern of arterial pressure was observed, variations were mostly associated with presence of human beings. Administration of L-NAME, but not lisinopril, altered this diurnal pattern.”

Brown et al. · Authors' conclusion

Names L-Arginine and Lisinopril together in an interaction, co-administration, or pharmacokinetic context.

Limitations

What this evidence cannot tell you.

Search-based evidence indexes have real limits, and it is worth being explicit about them:

NutriStack

Track what you actually take.

NutriStack is a free iPhone app for organising a supplement routine: what you take, when, and what the published record says about it. Its exploratory interaction checker covers L-Arginine, Lisinopril, and several hundred other substances.

The checker is a research and organisation tool, not a clinical decision aid, and its per-pair assessments are excluded from search until they pass claim-level review.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.